Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 6, Pages 2576-2589
Publisher
American Society for Clinical Investigation
Online
2013-05-07
DOI
10.1172/jci68143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma
- (2012) Zhenbing You et al. Clinical & Translational Oncology
- Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
- (2012) Priya Koppikar et al. NATURE
- Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
- (2012) P. van Hagen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3
- (2011) Olga A. Guryanova et al. CANCER CELL
- CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
- (2011) Terence Kin Wah Lee et al. Cell Stem Cell
- Reciprocal Activation Between PLK1 and Stat3 Contributes to Survival and Proliferation of Esophageal Cancer Cells
- (2011) Yu Zhang et al. GASTROENTEROLOGY
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
- (2011) Animesh Pardanani et al. JOURNAL OF CLINICAL ONCOLOGY
- The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
- (2011) Daniela Ungureanu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44
- (2011) Jiang-Sha Zhao et al. PLoS One
- Clinical Significance of GPR56, Transglutaminase 2, and NF-κB in Esophageal Squamous Cell Carcinoma
- (2010) Tasneem Kausar et al. CANCER INVESTIGATION
- Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion
- (2010) Liping Liu et al. CANCER RESEARCH
- The radiosensitization effect of NS398 on esophageal cancer stem cell-like radioresistant cells
- (2010) S.-M. Che et al. DISEASES OF THE ESOPHAGUS
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation
- (2010) R. B. Corcoran et al. Science Signaling
- Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas
- (2009) Sheng-Dong Huang et al. BMC CANCER
- Expression of Autotaxin and Acylglycerol kinase in prostate cancer: Association with cancer development and progression
- (2009) Mohammed Ahmed Abdel Muneem Nouh et al. CANCER SCIENCE
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- Targeting NF- B signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer
- (2009) B. Li et al. MOLECULAR CANCER THERAPEUTICS
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
- (2009) Adam J Bass et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started